MDWD
Income statement / Annual
Last year (2025), MediWound Ltd's total revenue was $16.96 M,
a decrease of 16.14% from the previous year.
In 2025, MediWound Ltd's net income was -$23.88 M.
See MediWound Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$16.96 M |
$20.22 M |
$18.69 M |
$26.50 M |
$23.76 M |
$21.76 M |
$31.79 M |
$3.40 M |
$2.50 M |
$1.56 M |
| Cost of Revenue |
$13.71 M
|
$17.59 M
|
$15.11 M
|
$13.33 M
|
$14.99 M
|
$14.22 M
|
$11.85 M
|
$2.09 M
|
$1.58 M
|
$2.16 M
|
| Gross Profit |
$3.25 M
|
$2.63 M
|
$3.58 M
|
$13.17 M
|
$8.77 M
|
$7.55 M
|
$19.94 M
|
$1.31 M
|
$918.00 K
|
-$600.00 K
|
| Gross Profit Ratio |
0.19
|
0.13
|
0.19
|
0.5
|
0.37
|
0.35
|
0.63
|
0.39
|
0.37
|
-0.39
|
| Research and Development Expenses |
$14.32 M
|
$8.88 M
|
$7.47 M
|
$10.18 M
|
$10.26 M
|
$7.70 M
|
$4.97 M
|
$4.07 M
|
$5.46 M
|
$7.07 M
|
| General & Administrative Expenses |
$10.06 M
|
$9.71 M
|
$8.57 M
|
$8.33 M
|
$7.75 M
|
$7.05 M
|
$5.00 M
|
$3.76 M
|
$3.73 M
|
$4.02 M
|
| Selling & Marketing Expenses |
$3.87 M
|
$3.20 M
|
$2.80 M
|
$2.04 M
|
$1.70 M
|
$1.45 M
|
$4.06 M
|
$4.19 M
|
$5.36 M
|
$8.40 M
|
| Selling, General & Administrative Expenses |
$13.93 M
|
$12.91 M
|
$11.38 M
|
$10.37 M
|
$9.45 M
|
$8.50 M
|
$9.06 M
|
$7.94 M
|
$9.09 M
|
$12.42 M
|
| Other Expenses |
$288.00 K
|
$228.00 K
|
$235.00 K
|
$274.00 K
|
$283.00 K
|
$190.00 K
|
$1.42 M
|
-$6.74 M
|
$56.00 K
|
$66.00 K
|
| Operating Expenses |
$28.53 M
|
$22.02 M
|
$19.08 M
|
$20.83 M
|
$19.99 M
|
$16.39 M
|
$15.45 M
|
$5.27 M
|
$14.61 M
|
$19.56 M
|
| Cost And Expenses |
$42.24 M
|
$39.60 M
|
$34.19 M
|
$34.16 M
|
$34.98 M
|
$30.60 M
|
$27.30 M
|
$7.36 M
|
$16.18 M
|
$21.71 M
|
| Interest Income |
$1.86 M
|
$2.05 M
|
$2.34 M
|
$270.00 K
|
$11.00 K
|
$297.00 K
|
$434.00 K
|
$412.00 K
|
$349.00 K
|
$414.00 K
|
| Interest Expense |
$663.00 K
|
$561.00 K
|
$335.00 K
|
$162.00 K
|
$167.00 K
|
$200.00 K
|
$207.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.86 M
|
$1.48 M
|
$1.30 M
|
$1.27 M
|
$1.24 M
|
$1.09 M
|
$1.15 M
|
$577.00 K
|
$567.00 K
|
$589.00 K
|
| EBITDA |
-$21.47 M |
-$27.93 M |
-$4.80 M |
-$18.25 M |
-$11.38 M |
-$7.35 M |
$4.14 M |
-$4.20 M |
-$13.14 M |
-$17.45 M |
| EBITDA Ratio |
-1.27
|
-1.38
|
-0.26
|
-0.69
|
-0.48
|
-0.34
|
0.13
|
-1.23
|
-5.26
|
-11.2
|
| Operating Income Ratio |
-1.49
|
-0.96
|
-0.83
|
-0.29
|
-0.47
|
-0.41
|
0.14
|
-1.16
|
-5.48
|
-12.94
|
| Total Other Income/Expenses Net |
$1.57 M
|
-$10.78 M
|
$8.97 M
|
-$11.86 M
|
-$2.30 M
|
-$436.00 K
|
-$2.43 M
|
-$1.71 M
|
-$846.00 K
|
$1.27 M
|
| Income Before Tax |
-$23.71 M
|
-$30.16 M
|
-$6.53 M
|
-$19.52 M
|
-$13.52 M
|
-$9.28 M
|
$2.07 M
|
-$5.67 M
|
-$14.53 M
|
-$18.89 M
|
| Income Before Tax Ratio |
-1.4
|
-1.49
|
-0.35
|
-0.74
|
-0.57
|
-0.43
|
0.06
|
-1.67
|
-5.82
|
-12.12
|
| Income Tax Expense |
$169.00 K
|
$61.00 K
|
$185.00 K
|
$78.00 K
|
$27.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$23.88 M
|
-$30.22 M
|
-$6.72 M
|
-$19.60 M
|
-$13.55 M
|
-$9.20 M
|
$4.96 M
|
-$1.06 M
|
-$22.15 M
|
-$18.89 M
|
| Net Income Ratio |
-1.41
|
-1.49
|
-0.36
|
-0.74
|
-0.57
|
-0.42
|
0.16
|
-0.31
|
-8.87
|
-12.12
|
| EPS |
-2.1 |
-3.03 |
-0.75 |
-3.93 |
-3.48 |
-2.38 |
1.26 |
-0.28 |
-6.64 |
-6.05 |
| EPS Diluted |
-2.1 |
-3.03 |
-0.75 |
-3.93 |
-3.48 |
-2.38 |
1.26 |
-0.28 |
-6.64 |
-6.05 |
| Weighted Average Shares Out |
$11.38 M
|
$9.96 M
|
$9.01 M
|
$4.99 M
|
$3.89 M
|
$3.89 M
|
$3.88 M
|
$3.87 M
|
$3.33 M
|
$3.12 M
|
| Weighted Average Shares Out Diluted |
$11.38 M
|
$9.96 M
|
$9.01 M
|
$4.99 M
|
$3.89 M
|
$3.89 M
|
$3.88 M
|
$3.87 M
|
$3.33 M
|
$3.12 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
